Bristol Myers Squibb

A combination of the right team, mentors and leaders motivates drug discovery researchers like Ari to keep pushing the boundaries of science. See how our innovative culture drives transformative science: https://bit.ly/4hY6TO9 #OneBMS

To target disease-causing proteins, previously considered “undruggable,” our scientists are investigating three different modalities for targeted protein degradation. Harnessing this three-pronged approach provides more opportunities for breakthroughs that may offer meaningful new options for a broad range of patients, including those living with #MultipleMyeloma. See how we’re fighting disease-causing proteins with molecular glues: https://bit.ly/4gXnX5y #MyelomaActionMonth #OneBMS

At the heart of our mission to deliver transformative, personalized medicines to patients is the collective expertise, dedication and collaboration of our incredible team. With so many key players working together, it takes seamless cross-functional teamwork to transform cutting-edge science into tangible solutions for patients. Our #CellTherapy Organization is pushing the boundaries of science to bring these custom treatments to patients worldwide. Learn more about the incredible individuals and teams driving this work. #OnACellularLevel #OneBMS https://bit.ly/3DMcF6D

The European Commission has approved our #CARTcelltherapy for patients living with relapsed or refractory follicular lymphoma (FL). This additional indication marks another leap forward in our mission to expand the transformative potential of cell therapy to more patients living with incurable blood cancers around the world. Learn more: https://bit.ly/4hzm7Ic

We’re excited to share our Inside the Science platform for HCPs looking to delve deeper into #psoriasis and #psoriaticarthritis disease education. Register to access valuable insights, including medical videos: https://bit.ly/4kcaBoZ #AAD2025 #DermatologyResearch #RheumatologyResearch #OneBMS

As part of our efforts within the Librexia program, we recently brought together female cardiologists Roxana Mehran, M Cecilia Bahit and Jennifer Li, and patients Mellanie True Hills, CSP and Dr. ShantaQuilette (Dr. Q) Develle, MBA, CPLC, MH, EA to discuss the underrepresentation of women and people of color in clinical trials and how the cardiovascular community can address these barriers to create an equitable future in cardiovascular care. Watch the discussion here: https://bit.ly/4hOfv9R #OneBMS

At #AAD2025, we presented data from our pivotal Phase 3 study for an investigational medicine in adults with #PsoriaticArthritis. For more than two decades, our team has pioneered research on novel pathways and approaches in Immunology, resulting in a better understanding of conditions like psoriatic disease. Learn more about psoriatic arthritis: https://bit.ly/419IYE3 #OneBMS

Every day, our colleagues around the world #AccelerateAction for equal opportunities and gender inclusion, led by the BMS Network of Women (B-NOW). Join us in celebrating #IWD2025 and our female colleagues who are transforming the lives of patients through science.

Inclusive medicine requires inclusive science. It’s critical we continue to make careers in science accessible to all. This International Women's Day, check out some advice our scientists have for the next generation and how to inspire more young people to pursue #STEM careers. #IWD2025 #WomenInScience #OneBMS